Ability Biologics
Ability Biologics uses generative AI to discover and develop potent and selective antibody therapeutics for cancer and immune-related disorders. Its AbiLeap discovery engine generates novel antibodies with the potential to be best-in-class or first-in-class therapeutics by targeting specific tissues and cells based on the local microenvironment. This approach addresses limitations of traditional antibody therapies.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $18M
Date: 18-Jun-2024
Investors: Amplitude Ventures, Fonds de solidarité FTQ, Investissement Québec, Charles River Laboratories, Theodorus, Alexandria Venture Investments
Markets: Biotechnology, AI, Therapeutics, Antibody Discovery, Life Science, Drug Discovery, Oncology
HQ: Montreal, Quebec, Canada
Founded: 2023
Website: https://www.ability.bio/
LinkedIn: https://www.linkedin.com/company/ability-biologics/
Crunchbase: https://www.crunchbase.com/organization/ability-biologics
Leave a Comment
Comments
No comments yet.